e-learning
resources
Vienna 2003
Tuesday 30.09.2003
Mechanisms of epithelial cell activation II
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Exhaled breath CO and induced sputum in noninvasive assessment of COPD
F. Romano, M. I. Scarlato, M. Gervasi, A. Mancuso, G. Bruni, A. Spanevello, S. Barbera (Cosenza, Cassano delle Murge, Italy)
Source:
Annual Congress 2003 - Mechanisms of epithelial cell activation II
Session:
Mechanisms of epithelial cell activation II
Session type:
Thematic Poster Session
Number:
2898
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Romano, M. I. Scarlato, M. Gervasi, A. Mancuso, G. Bruni, A. Spanevello, S. Barbera (Cosenza, Cassano delle Murge, Italy). Exhaled breath CO and induced sputum in noninvasive assessment of COPD. Eur Respir J 2003; 22: Suppl. 45, 2898
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
A 62-year-old man with scanty mucoid sputum
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Prediction of CF exacerbations by FeNO and non-invasive inflammatory markers in exhaled breath condensate
Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation
Year: 2008
Exhaled breath condensate for evaluation of inflammation in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 35s
Year: 2006
Exhaled breath condensate pH standardised for CO2 partial pressure
Source: Eur Respir J 2007; 29: 496-501
Year: 2007
Prediction of asthma exacerbations in children by FeNO and non-invasive inflammatory markers in exhaled breath condensate
Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children
Year: 2008
Noninvasive assessment of airway inflammation in asthma
Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=164
Year: 2003
Exhaled breath condensates and COPD
Source: Eur Respir J 2009; 33: 1238
Year: 2009
Exhaled breath temperature increases at COPD exacerbation and correlates with sputum neutrophilia
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011
Exhaled breath condensate biomarkers in COPD
Source: Eur Respir J 2008; 32: 472-486
Year: 2008
Content of nitric oxide in the exhaled breath condensate, induced sputum and BAL in asthma and COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 369s
Year: 2006
Nitrite concentration in exhaled breath condensate correlates with markers of lung overdistension in COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 317s
Year: 2004
Exhaled breath temperature in COPD patients
Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases
Year: 2012
Diagnostic value of induced sputum and nitric oxide in exhaled breath condensate to control treatment of bronchial asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 503s
Year: 2006
Exhaled breath condensate eicosanoids as markers of asthma severity
Source: Annual Congress 2008 - Understanding the mechanisms and the impact of severe asthma
Year: 2008
Markers of airway diseases in exhaled breath condensate and their clinical value
Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases
Year: 2013
Exhaled NO and exhaled breath condensate pH as predictors of sputum cell counts in optimally treated smoking asthmatics
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010
Comparison between exhaled and sputum oxidative stress biomarkers in chronic airway inflammation
Source: Eur Respir J 2004; 24: 1011-1017
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept